Cutaneous Small-vessel Vasculitis after ChAdOx1 COVID-19 Vaccination: A Report of Five CasesChAdOx1 COVID-19 예방접종 후 피부 소혈관염: 5건의 보고Case Reports Published on 2022-06-012022-09-11 Journal: The international journal of lower extremity wound [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome adverse event Affect Antihistamines arteries Arterioles Autoimmunity Capillaries ChAdOx1 ChAdOx1 COVID-19 vaccine clinician coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination Cutaneous Cutaneous Small-vessel Vasculitis defined demonstrated detectable FIVE lesion lower limb lower limbs Methylprednisolone one patient organs pandemic Pathogenesis Patient pregnant women reaction report reported required SARS-CoV-2 Severe acute respiratory syndrome small blood vessels South Korea spread to Steroids Symptom upper limb upper limbs vaccination Vasculitis women [DOI] 10.1177/15347346221078734 PMC 바로가기 [Article Type] Case Reports
Neuromuscular complications after COVID-19 vaccination: a series of eight patients코로나19 예방접종 후 신경근 합병증: 8명의 환자 연속Case Reports Published on 2022-06-012022-09-11 Journal: Acta neurologica Belgica [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 association brachial can not Care Case series case sery causal relationship chronic inflammatory demyelinating polyneuropathy CIDP classical collected Complication Coronavirus-2 COVID-19 COVID-19 vaccination COVID-19 vaccine disorder eight Epidemiological study etiology Guillain-Barré Guillain-barrè syndrome Immune-mediated include Infection Inflammatory limbs neurologic Neuromuscular one patient paresthesia Patient phenotype Phenotypes Polyneuropathy receiving reported SARS-CoV-2 second dose secondary care syndrome the vaccine two patients vaccination Vaccine variant weakness with COVID-19 [DOI] 10.1007/s13760-022-01941-0 PMC 바로가기 [Article Type] Case Reports
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis다발성 경화증에 대한 면역 조절 요법 전반에 걸친 COVID-19 백신에 대한 차별적인 항체 반응Article Published on 2022-06-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] MERS, 진단, [키워드] 95% CI Acetate Analysis analyzed anti-CD20 anti-CD20 therapy anti-spike antibody antibodies antibody Antibody Response Antibody test Antibody testing B-cell benefit booster vaccinations cells cellular clinical Cohort COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines determine evaluate Final fumarate higher odd humoral identify immunomodulatory effects immunomodulatory therapy Immunosuppressed individual interferons Johnson & Johnson lymphopenia median mediated immunity Moderna mRNA Multiple multiple sclerosis multivariable logistic regression multivariate one patient Patient patients Pfizer phosphate populations positive positive antibody response Post-vaccine predicted predictor reduced SAS significantly Studio Therapies therapy Vaccine vaccine dose Viral vector were used [DOI] 10.1016/j.msard.2022.103737 PMC 바로가기 [Article Type] Article
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis혈전 예방에도 불구하고 입원한 SARS-CoV-2 감염 환자에서 폐혈전색전증의 높은 발생률Observational Study Published on 2022-05-012022-09-11 Journal: Heart & lung : the journal of critical care [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] Admission age caused Characteristics Coagulation Computed tomography coronavirus COVID-19 COVID-19 pneumonia CTPA D-dimer levels diagnosed Diagnosis died Endothelial cell endothelial cells European hospital hospitalised Hospitalization Hospitalized incidence infected patient Infection Injury median age much lower Negative PCR no differences no significant differences non-infected Observational cohort study one patient Patient patient mortality patients patients with COVID-19 patients with PE performed Pneumonia Pulmonary thromboembolism reported retrospective observational cohort study SARS-CoV-2 SARS-CoV-2 infected patient SARS-CoV-2 infected patients SARS-CoV2 Sex significant difference study period suspicion the patient those without PE Thromboembolism thrombosis thrombotic thrombotic complication Thrombotic complications two groups virus infection VTE [DOI] 10.1016/j.hrtlng.2022.02.003 PMC 바로가기 [Article Type] Observational Study
COVID-19 severity and SARS-Cov-2 vaccine safety in pemphigus patients천포창 환자의 COVID-19 중증도 및 SARS-Cov-2 백신 안전성Multicenter Study Published on 2022-05-012022-09-12 Journal: Dermatologic therapy [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] asked Autoimmune blistering Characteristics clinics collected Course COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 severity demographic data Dermatology died disease Diseases feature Hospitalization Immunosuppressant immunosuppressants investigated multicenter one patient outpatient clinic Patient patients pemphigus question required rituximab RTX SARS-CoV-2 System the disease Treatment Vaccine Vaccines [DOI] 10.1111/dth.15417 PMC 바로가기 [Article Type] Multicenter Study
Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 20212021년 11월-12월 프랑스 마르세유에서 발생한 최초의 1119 SARS-CoV-2 Omicron 변종 사례의 특성Article Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-SARS-CoV-2 antibodies booster dose coronavirus COVID-19 death Delta diagnosed died dose France Hospitalization Hospitalized Infection intensive care intensive care unit Marseille omicron one patient Patient required SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus the vaccine vaccination Vaccination Status Vaccine variant [DOI] 10.1002/jmv.27613 PMC 바로가기 [Article Type] Article
Host-pathogen dynamics in longitudinal clinical specimens from patients with COVID-19COVID-19 환자의 종단 임상 표본에서 숙주-병원체 역학Article Published on 2022-04-072022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 임상, 진단, 치료기술, 치료법, [키워드] Analysis average bacterial species bacterial specy ciliated ciliated epithelium co-occurrence collected consensus genome Course COVID-19 cycle threshold cytoskeletal declined deep sequencing deletion variant Differential gene expression differential gene expression analysis dissemination downregulation enrichment Frequency Genetic Genome globe highlight Hospitalized Host immune pressure in vivo increase in individuals Infection low frequencies metagenomic N-terminal domain neutralization potency nonsynonymous variant nonsynonymous variants one patient Patient patients with COVID-19 per day performed Prevalence Rapid reduced Repository SARS-CoV-2 SARS-CoV-2 consensus sequence SARS-CoV-2 consensus sequences SARS-CoV-2 sequencing sequenced Sequencing sera shown specimen spike glycoprotein state subset Surveillance variants Viral viral evolution viral genomes viral loads Washington widespread [DOI] 10.1038/s41598-022-09752-2 PMC 바로가기 [Article Type] Article
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19초기 경증 내지 중등도의 COVID-19 환자 치료를 위한 소포스부비르/벨파타스비르 조합의 효능 및 안전성Multicenter Study Published on 2022-04-062022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 신약개발, 임상, 치료법, 치료제, [키워드] Antiviral case-control study clearance clinical outcomes Combination conducted Control control group COVID-19 died Disease progression effective evaluated faster HCV Health health problem Infection Intensive median Mild Moderate COVID-19 multicenter nasal swabs once daily one patient oxygen Patient patients PCR performed prevent disease progression primary endpoint RdRP RdRp inhibitor Replication required RNA-dependent RNA polymerase Safe SARS-CoV-2 SARS-CoV-2 clearance SARS-COV-2 infection secondary endpoint Side effect sofosbuvir standard care Swab Tablet the patient treat treated Treatment Vaccines velpatasvir Ventilation viral clearance [DOI] 10.1038/s41598-022-09741-5 PMC 바로가기 [Article Type] Multicenter Study
COVID-19 vaccine associated demyelination & its association with MOG antibodyCOVID-19 백신 관련 탈수초화 및 MOG 항체와의 관련성Article Published on 2022-04-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age antibody association AstraZeneca Central nervous system ChAdOx1-S CNS CNS DEMYELINATION Complication control group COVID-19 COVID-19 vaccine CSF Demyelination died effective Encephalopathy FIVE glycoprotein immunogenic Infection lesion MOG multiaxial Myelin neurological adverse event occurred one patient Patient patients positive postvaccinial prolonged intensive care Protein raise raised reported Safe SARS-CoV-2 vaccine SARS-CoV-VACCINE. significantly higher susceptible individuals the vaccine triggered vaccination Vaccinations Vaccine [DOI] 10.1016/j.msard.2022.103739 PMC 바로가기 [Article Type] Article
Liver or Kidney Transplantation After SARS-CoV-2 Infection: Prevalence, Short-term Outcome, and Kinetics of Serum IgG AntibodiesSARS-CoV-2 감염 후 간 또는 신장 이식: 혈청 IgG 항체의 유병률, 단기 결과 및 동역학Article Published on 2022-04-012022-09-11 Journal: Transplantation [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Absolute level absolute levels acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 analyzed anti-S IgG antibody Chain Reaction Clinical sign Clinical signs Cohort Coronavirus-2 Course declined detectable died Follow-up IgG IgG antibodies IgG antibody Immunoglobulin Immunoglobulin G individuals Infection kidney Kinetics liver median median interval Nasopharyngeal swab one patient organ transplantation outcome Patient patients paucity of data polymerase chain polymerase chain reaction positive positively correlated Prevalence remained respiratory SARS-CoV-2 SARS-COV-2 infection selected seroconverted patient Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus significantly lower solid organ solid organ transplantation symptom resolution transplantation Viral viral shedding [DOI] 10.1097/TP.0000000000003955 PMC 바로가기 [Article Type] Article